MedPath

The effect of a social robot on pain and behavioural and psychological symptoms in people with dementia: A pilot randomised controlled study

Not Applicable
Completed
Conditions
Dementia care
Neurological - Dementias
Mental Health - Depression
Mental Health - Anxiety
Registration Number
ACTRN12618000082202
Lead Sponsor
Griffith University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
43
Inclusion Criteria

(1) Aged 65 years and older who can understand and speak English or Mandarin.
(2) Participants must have been diagnosed with some form of dementia or probable diagnosis of dementia by staff.
(3) Being prescribed pain medications or an indication of pain (intensity * frequency greater than or equal to 2) according to two questions about pain intensity and frequency from the Minimum Data Set of the Resident Assessment Instrument (MDS-RAI)-pain scale. For those who cannot self-report pain, proxy pain reports of residents in the previous week will be obtained.
(4) Display of at least one of the sensory characteristics, e.g., vision, hearing or touch; and (5) Living in a care facility for more than 3 months (to avoid the potential anxiety and distress caused by a new environment).

Exclusion Criteria

(1) Diseases such as acute exacerbation of chronic obstructive pulmonary disease or renal failure that requires admission to the hospital frequently.
(2) Terminal illnesses such as advanced cancer where the patient is in the final palliative stage.
(3) A diagnosis of a major mental illness such as schizophrenia.
(4) Infectious diseases such as AIDS or tuberculosis or wounds that cannot be adequately covered.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change of the pain level measured by two ways: (1) self-reports of pain measured by The Revised Iowa Pain Thermometer (IPT-R) ; (2) researcher's observation of pain behaviour using The Pain Assessment in Advanced Dementia (PAINAD).[Baseline and immediately post-intervention ]
Secondary Outcome Measures
NameTimeMethod
Change of agitation being assessed by the Cohen-Mansfield Agitation Inventory – Short Form (CMAI-SF)[Baseline and immediately post-intervention ];Change of depression being assessed by the Cornell Scale for Depression in Dementia (CSDD)[Baseline and immediately post-intervention ];Change of anxiety being assessed by the Rating Anxiety in Dementia (RAID)[Baseline and immediately post-intervention ];Physiological indicators (e.g. heart rate, physical activity and sleep duration being assessed by the SenseWear armband and the level of salivary cortisol).[Baseline and immediately post-intervention ];Pain medication consumption being assessed by the Modification Quantification Scale Version III (MQS III )[Baseline and immediately post intervention ]
© Copyright 2025. All Rights Reserved by MedPath